Charleston, SC -- (SBWIRE) -- 01/22/2014 -- otcstockcenter.com, provide information specifically for trades in the micro-cap market. Micro caps are companies with a capitalization between $50 million and $300 million. We provide the information active traders need, when they need it. By combining our research capabilities with our instant alerts, subscribers are able to better determine trading strategies and execute those strategies faster. Let’s have a look on Few Hot Stocks: MELA Sciences Inc (NASDAQ:MELA), ThermoGenesis Corp (NASDAQ:KOOL), ImmunoCellular Therapeutics Ltd (NYSEMKT:IMUC), IAMGOLD Corp (USA) (NYSE:IAG)
MELA Sciences Inc (NASDAQ:MELA) was trading higher by 0.033 points or 4.61% to $0.749.So far, around 3.26 million shares have changed hands in this session. After opening at $0.75, the stock hit as high as $0.89. However, it traded between $0.63 and$1.83 over the last twelve months. MELA Sciences, Inc. is a medical device company focused on the commercialization of its product, MelaFind, and the further design and development of MelaFind and its technology. MelaFind is a non-invasive, point-of-care (in the doctor's office) instrument to aid in the detection of melanoma.
For How Long MELA will Fight for Profitability? Read This Trend Analysis report
ThermoGenesis Corp (NASDAQ:KOOL) added 22.17% recently, in the current trading session, at $2.81 with a total volume of 19.83M shares. The stock, on average, trades on a volume of 657,660.00 shares. It floated in a range of $2.62 to $3.24 during the recent trading session, with a beta value of 1.27. Its market capitalization now moved to about $47.70M. In the past 52 weeks, the share price has not declined below $0.71 and failed to cross $3.24. ThermoGenesis Corp., designs, develops and commercializes devices and disposable tools for the processing, storage and administration of cell and tissue therapies used in the practice of regenerative medicine.
For How Long KOOL Gloss will Attract Investors? Find out via this report
ImmunoCellular Therapeutics Ltd (NYSEMKT:IMUC) moved -9.74 per cent lower at $1.39 and is trading between $1.31 and $1.45 after opening the day at $4.00. Its performance over the last five days remained 39.53%, which stands at 71.34% for a month. Going back further than one month, 1-year performance after recent close was 49.19%. ImmunoCellular Therapeutics, Ltd. is a clinical-stage biotechnology company. The Company is engaged in developing immune-based therapies for the treatment of cancers, such as brain, ovarian and other solid tumors.
Why Should Investors Buy IMUC After the Recent Fall? Just Go Here and Find Out
IAMGOLD Corp (USA) (NYSE:IAG) shares decline today, losing -10.49 per cent to $3.67. The stock is up around 11.41% in 2013 and -65.87% for the last 12 months. Around 9.70 million shares changed hands so far in this session compared to an-average trading volume of 7.52M shares. IAMGOLD Corporation (IAMGOLD) is a mining company. IAMGOLD‘s interests include five operating gold mines, a niobium mine, a diamond royalty, and exploration and development projects located in Africa and the Americas.
Will IAG Get Buyers Even After The Recent Rally? Find Out Here
About OTC Stock Center
We provide the information active traders need, when they need it. By combining our research capabilities with our instant alerts, subscribers are able to better determine trading strategies and execute those strategies faster. More trades can mean more profits to those who can take advantage of the picks included with our service. We provide high quality picks in a timely fashion so that you are free to do what you do best, which is trade for profit. Alertness.
Markets move on information. Our subscribers get our picks fast and first by signing up for our email and text alerts. This information is exclusively for our readers, but once it’s out, the markets move and move fast. Getting the right information is always important, getting it first and in time to be able to build your trades is even more important. Don’t miss out on the chance to take your trading to the next level.
OTC Stock Center’s sponsored advertisements do not purport to provide an analysis of any company’s financial position, operations or prospects and this is not to be construed as a recommendation by OTC Stock Center or an offer or solicitation to buy or sell any security. Neither the owner of OTC Stock Center nor any of its members, officers, directors, contractors or employees is licensed broker-dealers, account representatives, market makers, investment bankers, investment advisors, analyst or underwriters. Investing in securities, including the securities of those companies profiled or discussed on this website is for individuals tolerant of high risks. Viewers should always consult with a licensed securities professional before purchasing or selling any securities of companies profiled or discussed in our releases.
Please read Our Full Disclaimer at: http://otcstockcenter.com/disclaimer/
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)